Grifols to present latest Alzheimer's clinical trial results

BARCELONA, Spain, Dec. 2, 2019 /PRNewswire/ -- Grifols (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), a leading global producer of plasma-derived medicines, will present the final and complete clinical, biomarker and neuroimaging results of its AMBAR (Alzheimer......
. .
Veröffentlicht von: Finanzen.at - Nachrichten Ticker - 6 days ago

Share |